Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery
Sponsor: M.D. Anderson Cancer Center
Trial Details
| Condition | Breast Cancer |
| Intervention | Questionnaires; Questionnaires; Questionnaires |
| Phase | NA |
| Status | Not_yet_recruiting |
| Participants | 50 |
| Est. Completion | 31 Dec 2027 |
| Last Updated | 27 July 2026 |
Primary Outcome
Safety and Adverse Events (AEs)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Age ≥ 18 years. * Scheduled for delayed\[SH6.1\]\[PH6.2\] unilateral or bilateral DIEP flap breast reconstruction. * Able and willing to provide informed consent. * Possession of a compatible smartphone or tablet capable of syncing with the Fitbit Inspire 3 app. * Willingness to wear the activity tracker continuously for three weeks preoperatively and three months postoperatively. Exclusion Criteria: * Inability or unwillingness to wear a wrist-worn activity tracker. * Significant dermatologic conditions, wound, or allergy preventing safe use of a wrist-worn device. * Planned additional concurrent surgical procedure (non-reconstructive) expected to significantly alter activity level or recovery trajectory (i.e. BSO, CPM). * Participation in another interventional clinical trial that may confound activity or recovery data. * Inability to provide informed consent or complete required questionnaires.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service